Kyalin Biosciences Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 1

Kyalin Biosciences General Information

Description

Manufacturer and developer of therapies targeting the core symptoms of autism and related conditions. The company provides oxytocin for the treatment of autistic spectrum disorders.

Contact Information

Website
www.kyalinbio.com
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 1477 Paseo de las Flores
  • Encinitas, CA 92024
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Acquirer
Travere Therapeutics
Vertical(s)
Manufacturing
Corporate Office
  • 1477 Paseo de las Flores
  • Encinitas, CA 92024
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Kyalin Biosciences Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Kyalin Biosciences‘s full profile, request access.

Request a free trial

Kyalin Biosciences Patents

  • 2

    Total Documents Applications and Grants

  • Total Patents Families

  • 1

    Granted

  • Pending

  • Expiring in next 12 mo

Kyalin Biosciences Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-2689476-A1 Intranasal carbetocin formulations and methods for the treatment of autism Active 07-Jun-2007
CA-2689476-C Intranasal carbetocin formulations and methods for the treatment of autism Inactive 07-Jun-2007

Kyalin Biosciences FAQs

  • When was Kyalin Biosciences founded?

    Kyalin Biosciences was founded in 2011.

  • Where is Kyalin Biosciences headquartered?

    Kyalin Biosciences is headquartered in Encinitas, CA.

  • What industry is Kyalin Biosciences in?

    Kyalin Biosciences’s primary industry is Drug Discovery.

  • Is Kyalin Biosciences a private or public company?

    Kyalin Biosciences is a Private company.

  • What is the current valuation of Kyalin Biosciences?

    The current valuation of Kyalin Biosciences is .

  • What is Kyalin Biosciences’s current revenue?

    The current revenue for Kyalin Biosciences is .

  • When was Kyalin Biosciences acquired?

    Kyalin Biosciences was acquired on 23-Dec-2013.

  • Who acquired Kyalin Biosciences?

    Kyalin Biosciences was acquired by Travere Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process